# Resynchronization Surgery Combined Unified Efficacy

> **NCT00846001** · PHASE3 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 178 (actual)

## Conditions studied

- Ischemic Heart Failure

## Interventions

- **PROCEDURE:** Coronary artery bypass grafting
- **DEVICE:** Epicardial implantation of cardiac resynchronization therapy device

## Key facts

- **NCT ID:** NCT00846001
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2015-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846001, "Resynchronization Surgery Combined Unified Efficacy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00846001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*